Refractory anti-viral resistant CMV retinitis in an immunological nonresponder person living with HIV
Cytomegalovirus (CMV) retinitis caused by drug-resistant viruses poses a major challenge in immunocompromised patients. We present the case of a patient living with HIV with persistently low CD4+ T cells count despite effective antiretroviral therapy, who experienced multiple episodes of CMV retinitis associated with iterative acquisition of resistance. The failure of ganciclovir and foscarnet treatments led us to implement a combined therapy of intravenous cidofovir, high-dose ganciclovir, and anti-CMV immunoglobulin as well as intravitreal injections of ganciclovir. This triple therapy was successful but resulted in significant myelotoxicity. Furthermore, the relapse of CMV retinitis and/or CMV viremia with each therapeutic de-escalation reflects the high level of immunodeficiency in our patient, despite sustained control of HIV viremia for several months. This case report highlights the need for a particular management of CMV infection in patients living with HIV who are immunological nonresponders.
Authors
- David Boutolleau (ORCID: https://orcid.org/0000-0001-9401-4662)
- Nadhira Fidouh
- Alexandra Serris
- Mayda Rahi (ORCID: https://orcid.org/0000-0002-2495-9406)
- C. Rioux (ORCID: https://orcid.org/0000-0003-2829-1412)
- Véronique Joly
Institutions
- Inserm (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Hôpital Bichat-Claude-Bernard (FR)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.ijid.2024.107229
- Citations
- 2
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.77